Odprti razpisi › Horizon Europe
Advancing bio-printing of living cells for regenerative medicine
Horizon Europe · Cluster 1 – Health · HORIZON-HLTH-2027-03-TOOL-02
Funds bio-printing technologies for living human cells, from GMP manufacturing to first-in-human regenerative medicine studies.
Ta razpis je napovedan, a še ni odprt. Datumi in pogoji se lahko še spremenijo.
O čem je ta razpis?
The topic funds research projects that develop bio-printing equipment for living human cells, scale it to GMP-compliant manufacturing and test it in first-in-human studies for regenerative medicine.
Kaj ta razpis financira?
Scope
The topic funds the development of complete bio-printing technologies that print high-cell-density constructs from human cells to repair or regenerate defective tissues or internal organs, and their translation into first-in-human studies. Both in-vitro printing followed by transplantation and in-situ printing directly on the target site during surgery are covered. Projects may address any therapeutic area.
Expected activities
Proposals should use human cells and address all of the following:
- Develop or improve bio-printing equipment covering all steps of the bio-printing process, to print high-cell-density constructs for better vascularisation and faster repair.
- Scale up the chosen technology to a manufacturing process conforming to Good Manufacturing Practices.
- Carry out the regulatory work needed for clinical studies and assess clinical value in first-in-human studies.
Priority goes to approaches that target vital internal organs followed by surgical grafting, or that deposit cell-laden bio-ink directly on the defect site from a printhead or endoscope. Requirements from EU frameworks on substances of human origin, medical devices and medicinal products, including advanced therapy medicinal products, should be considered. Preclinical and clinical development are eligible, and sex differences at the cellular level should be considered. Teams should be multidisciplinary.
Expected outcomes
- Biomedical scientists in academia and industry gain access to complete bio-printing units for regenerating human tissue.
- Healthcare professionals obtain information on the safe and effective use of this equipment.
- Patients benefit from personalised regenerative treatments for conditions of unmet medical need.
Ključni podatki o razpisu na kratko
- Proračun teme
- 39.300.000 €
- Najnižji znesek na projekt
- 7.000.000 €
- Najvišji znesek na projekt
- 10.000.000 €
- Oznaka razpisa
- HORIZON-HLTH-2027-03-TOOL-02
- Program
- Horizon Europe
- Funder
- Horizon Europe, Cluster 1 - Health
- Expected number of projects
- 4
Kdo se lahko prijavi na ta razpis?
- The action type is a Horizon Europe Research and Innovation Action.
- Documented contacts with relevant national or European regulatory authorities are desired.
- The European Commission Joint Research Centre may contribute to selected projects.
- Applicants should provide details of their clinical studies in the dedicated annex using the template in the submission system.
Preverite upravičenost in kako se vaš projekt ujema z razpisom
V brezplačnem računu za vašo organizacijo preverimo pogoje upravičenosti v razpisni dokumentaciji in ocenimo, kako dobro se vaš projekt ujema s tem razpisom.
Kaj se pričakuje od predlogov?
- Involvement of small and medium-sized enterprises (SMEs) is encouraged.
Kdaj je rok za oddajo?
16. septembra 2027 (314 dni)
22 September 2027 (single-stage submission).
Vas razpis zanima? Povzetek je pripravila umetna inteligenca iz uradne razpisne dokumentacije. Podrobnosti se lahko razlikujejo, zato pred prijavo preverite uradno stran razpisa. Pred odločitvijo preberite uradno razpisno dokumentacijo. Zavezujoče je vedno uradno besedilo.
Vir: portal EU Funding & Tenders in uradna razpisna dokumentacija. Uradna stran razpisa Zadnja posodobitev: 6. oktobra 2026.